BridgeBio Pharma, Inc. (BBIO)
68.09
-0.69
(-1.00%)
USD |
NASDAQ |
May 06, 16:00
68.11
+0.02
(+0.03%)
After-Hours: 07:07
BridgeBio Pharma Cash from Investing (Quarterly) : -13.75M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | 785.00M |
| Mirum Pharmaceuticals, Inc. | 1.006M |
| Insmed, Inc. | 389.41M |
| Eli Lilly & Co. | -3.916B |
| Alnylam Pharmaceuticals, Inc. | -25.54M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -56.42M |
| Cash from Financing (Quarterly) | -2.782M |
| Free Cash Flow | -455.50M |
| Free Cash Flow Per Share (Quarterly) | -0.2917 |
| Free Cash Flow to Equity (Quarterly) | -80.71M |
| Free Cash Flow to Firm (Quarterly) | -6.17M |
| Free Cash Flow Yield | -3.49% |